Behavioral and Molecular Biomarkers in Translational Animal Models for Neuropsychiatric Disorders

Author(s):  
Zoltán Sarnyai ◽  
Murtada Alsaif ◽  
Sabine Bahn ◽  
Agnes Ernst ◽  
Paul C. Guest ◽  
...  
2019 ◽  
Vol 42 ◽  
Author(s):  
Nicole M. Baran

AbstractReductionist thinking in neuroscience is manifest in the widespread use of animal models of neuropsychiatric disorders. Broader investigations of diverse behaviors in non-model organisms and longer-term study of the mechanisms of plasticity will yield fundamental insights into the neurobiological, developmental, genetic, and environmental factors contributing to the “massively multifactorial system networks” which go awry in mental disorders.


Author(s):  
Mikhail V. Pletnikov ◽  
Christopher A. Ross

Despite the recent advances in research into schizophrenia and bipolar disorder, the neurobiology of these maladies remains poorly understood. Animal models can be instrumental in elucidating the underlying mechanisms of neuropsychiatric disorders. Early animal models of schizophrenia and bipolar disorder used lesion methods, pharmacologic challenges or environmental interventions to mimic pathogenic features of the diseases. The recent progress in genetics has stimulated the development of etiological models that have begun to provide insight into pathogenesis. In this review, we evaluate the strengths and weaknesses of the existing genetic mouse models of schizophrenia and discuss potential developments for the future.


2019 ◽  
Vol 85 (2) ◽  
pp. 122-134 ◽  
Author(s):  
Madison DeCapo ◽  
Jacqueline R. Thompson ◽  
Geoffrey Dunn ◽  
Elinor L. Sullivan

Author(s):  
Lyonna F. Alcantara ◽  
Eric M. Parise ◽  
Carlos A. Bolaños-Guzmán

Animal modeling has advanced our understanding of the underlying pathophysiology of human neuropsychiatric disorders and facilitated development of safer, more efficient medications. Similar to humans with depression, rodents exposed to various stress paradigms exhibit aberrant responses to rewarding stimuli, along with hormonal and immunological dysregulation. Development of more complex models, such as social defeat, has led to a firmer grasp of the mechanisms mediating resilience and susceptibility to stress; and adapted versions of social defeat have yielded insights into how emotional stress influences development of mood disorders. This chapter focuses on stress-induced models of mood disorders and outlines how a depression-like phenotype is induced and tested in rodents.


2017 ◽  
Vol 68 (8) ◽  
pp. 1879-1883 ◽  
Author(s):  
Manuela Padurariu ◽  
Iulia Antioch ◽  
Alin Ciobica ◽  
Radu Lefter ◽  
Laurentiu Simion

There is an increased interest in the current literature in how relevant the administration of oxytocin, mostly by using its intranasal administration, could be in some neuropsychiatric disorders and especially in those manifesting a deficit at their sociability level. These aspects made the possible usage of oxytocin as extremely attractive for some management and treatment solutions in the autistic pathology. Thus, we are describing here some original data and current literature status on how oxytocin could help pathophysiological autistic manifestations in both animal models and human patients, by mainly focusing on some specific behavioural or pain manifestations and related oxidative stress status.


Sign in / Sign up

Export Citation Format

Share Document